Answers are grounded in this paper and cite their sources.
Introduction: Ferroptosis therapy, despite its promise, encounters challenges such as compromised catalytic performance due to an inadequate H 2 O 2 substrate, the robust antioxidant defense system within the tumor microenvironment (TME), and potential off-target adverse events, leading to suboptimal efficacy. Methods: To overcome these limitations, we propose a strategy for TME-mediated activation of a potent oxidative stress storm to enhance MRI-guided multiple-amplified ferroptosis therapy for tumors. Results: The synthesized Fe-LAP@HMON-TAM-PEOz nanoparticles demonstrate precise and highly effective tumor-specific catalysis for antitumor therapy. This is achieved through an improved tumor accumulation strategy driven by charge-reversal-mediated active targeting and a multiple amplification approach for ferroptosis therapy, involving H 2 O 2 self-supplementation, GSH depletion, subsequent oxidative stress storm generation, and LPO accumulation, resulting in a robust antitumor response. Furthermore, the rapid degradation of nanoparticles in response to the H + /GSH stimulus within the TME facilitates the release of Mn 2+ from Fe-LAP@HMON-TAM-PEOz. This released Mn 2+ significantly enhances tumor brightness in T 1 -weighted MRI, characterized by a high r 1 value. Conclusion: Consequently, our synthesized Fe-LAP@HMON-TAM-PEOz nanoparticles exhibit excellent biodegradability and minimal side effects, highlighting their tremendous potential for highly efficient tumor theranostics.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: